Copyright
©2014 Baishideng Publishing Group Inc.
World J Rheumatol. Jul 12, 2014; 4(2): 14-21
Published online Jul 12, 2014. doi: 10.5499/wjr.v4.i2.14
Published online Jul 12, 2014. doi: 10.5499/wjr.v4.i2.14
Table 3 Correlation of the World Health Organization fracture risk assessment tool stratified major osteoporotic and hip fracture 10-year probability with the total proximal femur bone mineral density measurement
BMD total proximal femur at baseline | BMD total proximal femur at 2-yr | BMD total proximal femur at 5-yr | |
FRAX 10-yr major osteoporosis fracture risk probability | -0.551b | -0.449b | -0.479b |
FRAX 10-yr hip fracture risk probability | -0.741b | -0.547b | -0.584b |
Change in FRAX 10-yr major osteoporosis fracture probability at 2-yr | -0.459b | ||
Change in FRAX 10-yr hip fracture probability at 2-yr | -0.557b | ||
Major osteoporosis fracture probability at 5-yr | -0.489b | ||
Change in FRAX 10-yr hip fracture probability at 5-yr | -0.594b |
- Citation: Miedany YE, Gaafary ME, Yassaki AE, Youssef S, Nasr A, Ahmed I. Monitoring osteoporosis therapy: Can FRAX help assessing success or failure in achieving treatment goals? World J Rheumatol 2014; 4(2): 14-21
- URL: https://www.wjgnet.com/2220-3214/full/v4/i2/14.htm
- DOI: https://dx.doi.org/10.5499/wjr.v4.i2.14